150 related articles for article (PubMed ID: 35368349)
1. G protein- and
Xiong X; Nazo N; Revoori R; Rajagopal S; Sparks MA
Kidney360; 2021 Jul; 2(7):1124-1131. PubMed ID: 35368349
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.
Teoh JP; Park KM; Wang Y; Hu Q; Kim S; Wu G; Huang S; Maihle N; Kim IM
Cell Signal; 2014 Dec; 26(12):2885-95. PubMed ID: 25194819
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human ETA and ETB receptor signalling via G-protein and β-arrestin pathways.
Maguire JJ; Kuc RE; Pell VR; Green A; Brown M; Kumar S; Wehrman T; Quinn E; Davenport AP
Life Sci; 2012 Oct; 91(13-14):544-9. PubMed ID: 22480514
[TBL] [Abstract][Full Text] [Related]
4. Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase.
Cianfrocca R; Rosanò L; Spinella F; Di Castro V; Natali PG; Bagnato A
Can J Physiol Pharmacol; 2010 Aug; 88(8):796-801. PubMed ID: 20725137
[TBL] [Abstract][Full Text] [Related]
5. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.
Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A
Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471
[TBL] [Abstract][Full Text] [Related]
6. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells.
Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L
Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737
[TBL] [Abstract][Full Text] [Related]
7. Biased agonists of the chemokine receptor CXCR3 differentially signal through Gα
Zheng K; Smith JS; Eiger DS; Warman A; Choi I; Honeycutt CC; Boldizsar N; Gundry JN; Pack TF; Inoue A; Caron MG; Rajagopal S
Sci Signal; 2022 Mar; 15(726):eabg5203. PubMed ID: 35316095
[TBL] [Abstract][Full Text] [Related]
8. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer.
Rosanò L; Bagnato A
J Exp Clin Cancer Res; 2016 Jul; 35(1):121. PubMed ID: 27473335
[TBL] [Abstract][Full Text] [Related]
9. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
[TBL] [Abstract][Full Text] [Related]
10. Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.
Allen JA; Yost JM; Setola V; Chen X; Sassano MF; Chen M; Peterson S; Yadav PN; Huang XP; Feng B; Jensen NH; Che X; Bai X; Frye SV; Wetsel WC; Caron MG; Javitch JA; Roth BL; Jin J
Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18488-93. PubMed ID: 22025698
[TBL] [Abstract][Full Text] [Related]
11. Non-HLA antibodies targeting angiotensin II Type 1 receptor and endothelin-1 Type A receptors induce endothelial injury via β2-arrestin link to mTOR pathway.
Catar RA; Wischnewski O; Chen L; Heidecke H; Rutz C; Schülein R; Dragun D; Philippe A; Kusch A
Kidney Int; 2022 Mar; 101(3):498-509. PubMed ID: 34757123
[TBL] [Abstract][Full Text] [Related]
12. Regulation and intracellular trafficking pathways of the endothelin receptors.
Bremnes T; Paasche JD; Mehlum A; Sandberg C; Bremnes B; Attramadal H
J Biol Chem; 2000 Jun; 275(23):17596-604. PubMed ID: 10747877
[TBL] [Abstract][Full Text] [Related]
13. Increased endothelin receptor B and G protein coupled kinase-2 in the mesentery of portal hypertensive rats.
Du QH; Han L; Jiang JJ; Li PT; Wang XY; Jia X
World J Gastroenterol; 2013 Apr; 19(13):2065-72. PubMed ID: 23599626
[TBL] [Abstract][Full Text] [Related]
14. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
[TBL] [Abstract][Full Text] [Related]
15. Discovery of β-arrestin-biased β
Woo AY; Ge XY; Pan L; Xing G; Mo YM; Xing RJ; Li XR; Zhang YY; Wainer IW; Cheng MS; Xiao RP
Acta Pharmacol Sin; 2019 Aug; 40(8):1095-1105. PubMed ID: 30643208
[TBL] [Abstract][Full Text] [Related]
16. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling.
Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A
Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497
[TBL] [Abstract][Full Text] [Related]
17. Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis.
Rosanò L; Cianfrocca R; Masi S; Spinella F; Di Castro V; Biroccio A; Salvati E; Nicotra MR; Natali PG; Bagnato A
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2806-11. PubMed ID: 19202075
[TBL] [Abstract][Full Text] [Related]
18. Endothelin receptor heteromerization inhibits β-arrestin function in HEK293 cells.
Zrein A; Bagher AM; Young AP; Denovan-Wright EM; Kelly MEM
Can J Physiol Pharmacol; 2020 Aug; 98(8):531-540. PubMed ID: 32744876
[TBL] [Abstract][Full Text] [Related]
19. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
[TBL] [Abstract][Full Text] [Related]
20. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]